These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 34365925)

  • 1. The Impact of Deranged Glucose Metabolism and Diabetes in the Pathogenesis and Prognosis of the Novel SARS-CoV-2: A Systematic Review of Literature.
    Ukwenya VO; Adelakun SA; Fuwape TA; Adeagbo AS
    Curr Diabetes Rev; 2022; 18(3):e060821195355. PubMed ID: 34365925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines Involved in COVID-19 Patients with Diabetes: A Systematic Review.
    George TP; Joy SS; Rafiullah M; Siddiqui K
    Curr Diabetes Rev; 2023; 19(3):e180122200321. PubMed ID: 35040414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced endocytosis elevated virulence and severity of SARS-CoV-2 due to hyperglycemia in type 2 diabetic patients.
    Subbaram K; Ali PSS; Ali S
    Gene Rep; 2022 Mar; 26():101495. PubMed ID: 35043090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes in the COVID-19 pandemic era.
    Bonansea TCP; Santos LPD; Zintl K; Souza ACDS
    Rev Assoc Med Bras (1992); 2021; 67Suppl 1(Suppl 1):157-162. PubMed ID: 34406303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review of Clinical Insights into Novel Coronavirus (CoVID-19) Pandemic: Persisting Challenges in U.S. Rural Population.
    Lakhani HV; Pillai SS; Zehra M; Sharma I; Sodhi K
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32549334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for COVID-19: Diabetes, Hypertension, and Obesity.
    Buscemi S; Corleo D; Randazzo C
    Adv Exp Med Biol; 2021; 1353():115-129. PubMed ID: 35137371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes Mellitus during the Pandemic Covid-19: Prevalence, Pathophysiology, Mechanism, and Management: An updated overview.
    Rais N; Ahmad R; Ved A; Parveen K; Ishrat T; Prakash O; Shadab M; Bari DG; Siddiqui NA
    Curr Diabetes Rev; 2022; 18(3):e120721194712. PubMed ID: 34931983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unwinding Link between Coronavirus and Diabetes Patient.
    Bhadauria SS; Malviya R; Sharma PK
    Endocr Metab Immune Disord Drug Targets; 2022; 22(11):1091-1110. PubMed ID: 35352656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.
    Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M
    Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?
    Pugliese G; Vitale M; Resi V; Orsi E
    Acta Diabetol; 2020 Nov; 57(11):1275-1285. PubMed ID: 32865671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Important Management Considerations In Patients With Pituitary Disorders During The Time Of The Covid-19 Pandemic.
    Yuen KCJ; Blevins LS; Findling JW
    Endocr Pract; 2020 Aug; 26(8):915-922. PubMed ID: 33471683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.
    Bajgain KT; Badal S; Bajgain BB; Santana MJ
    Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review.
    Pepera G; Tribali MS; Batalik L; Petrov I; Papathanasiou J
    Rev Cardiovasc Med; 2022 Jan; 23(1):28. PubMed ID: 35092220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.
    Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V
    Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 and diabetes-Two giants colliding: From pathophysiology to management.
    Pelle MC; Zaffina I; Provenzano M; Moirano G; Arturi F
    Front Endocrinol (Lausanne); 2022; 13():974540. PubMed ID: 36060943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impacts of SARS-CoV-2 on diabetes mellitus: A pre and post pandemic evaluation.
    Nabi AHMN; Ebihara A; Shekhar HU
    World J Virol; 2023 Jun; 12(3):151-171. PubMed ID: 37396707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and diabetes: A bidirectional relationship.
    Lima-Martínez MM; Carrera Boada C; Madera-Silva MD; Marín W; Contreras M
    Clin Investig Arterioscler; 2021; 33(3):151-157. PubMed ID: 33303218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of diabetes mellitus on in-hospital mortality in adult patients with COVID-19: a systematic review and meta-analysis.
    Kaminska H; Szarpak L; Kosior D; Wieczorek W; Szarpak A; Al-Jeabory M; Gawel W; Gasecka A; Jaguszewski MJ; Jarosz-Chobot P
    Acta Diabetol; 2021 Aug; 58(8):1101-1110. PubMed ID: 33778910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.